Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment

Sylwia Milewska,1 Katarzyna Niemirowicz-Laskowska,1 Gabriela Siemiaszko,2 Piotr Nowicki,1 Agnieszka Z Wilczewska,2 Halina Car1 1Department of Experimental Pharmacology, Medical University of Bialystok, Bialystok, 15-361, Poland; 2Faculty of Chemistry, University of Bialystok, Bialystok, 15-245, Pola...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Milewska S, Niemirowicz-Laskowska K, Siemiaszko G, Nowicki P, Wilczewska AZ, Car H
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	nanotechnology pharmacology pharmacoeconomic analysis pharmacoeconomics nanomaterials synthesis clinical trials Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/61a27f282df04deeb7f555f93121a95c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:61a27f282df04deeb7f555f93121a95c
record_format	dspace
spelling	oai:doaj.org-article:61a27f282df04deeb7f555f93121a95c2021-12-02T17:22:18ZCurrent Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment1178-2013https://doaj.org/article/61a27f282df04deeb7f555f93121a95c2021-09-01T00:00:00Zhttps://www.dovepress.com/current-trends-and-challenges-in-pharmacoeconomic-aspects-of-nanocarri-peer-reviewed-fulltext-article-IJNhttps://doaj.org/toc/1178-2013Sylwia Milewska,1 Katarzyna Niemirowicz-Laskowska,1 Gabriela Siemiaszko,2 Piotr Nowicki,1 Agnieszka Z Wilczewska,2 Halina Car1 1Department of Experimental Pharmacology, Medical University of Bialystok, Bialystok, 15-361, Poland; 2Faculty of Chemistry, University of Bialystok, Bialystok, 15-245, PolandCorrespondence: Katarzyna Niemirowicz-Laskowska; Halina CarDepartment of Experimental Pharmacology, Medical University of Bialystok, Szpitalna 37, Bialystok, 15-361, PolandTel +48602749149; +48604831512Email katarzyna.niemirowicz@umb.edu.pl; halina.car@umb.edu.plAbstract: Nanotherapy is a part of nanomedicine that involves nanoparticles as carriers to deliver drugs to target locations. This novel targeting approach has been found to resolve various problems, especially those associated with cancer treatment. In nanotherapy, the carrier plays a crucial role in handling many of the existing challenges, including drug protection before early-stage degradations of active substances, allowing them to reach targeted cells and overcome cell resistance mechanisms. The present review comprises the following sections: the first part presents the introduction of pharmacoeconomics as a branch of healthcare economics, the second part covers various beneficial aspects of the use of nanocarriers for in vitro, in vivo, and pre- and clinical studies, as well as discussion on drug resistance problem and present solutions to overcome it. In the third part, progress in drug manufacturing and optimization of the process of nanoparticle synthesis were discussed. Finally, pharmacokinetic and toxicological properties of nanoformulations due to up-to-date studies were summarized. In this review, the most recent developments in the field of nanotechnology’s economic impact, particularly beneficial applications in medicine were presented. Primarily focus on cancer treatment, but also discussion on other fields of application, which are strongly associated with cancer epidemiology and treatment, was made. In addition, the current limitations of nanomedicine and its huge potential to improve and develop the health care system were presented.Keywords: nanotechnology, pharmacology, pharmacoeconomic analysis, pharmacoeconomics, nanomaterials synthesis, clinical trialsMilewska SNiemirowicz-Laskowska KSiemiaszko GNowicki PWilczewska AZCar HDove Medical Pressarticlenanotechnologypharmacologypharmacoeconomic analysispharmacoeconomicsnanomaterials synthesisclinical trialsMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 6593-6644 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	nanotechnology pharmacology pharmacoeconomic analysis pharmacoeconomics nanomaterials synthesis clinical trials Medicine (General) R5-920
spellingShingle	nanotechnology pharmacology pharmacoeconomic analysis pharmacoeconomics nanomaterials synthesis clinical trials Medicine (General) R5-920 Milewska S Niemirowicz-Laskowska K Siemiaszko G Nowicki P Wilczewska AZ Car H Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment
description	Sylwia Milewska,1 Katarzyna Niemirowicz-Laskowska,1 Gabriela Siemiaszko,2 Piotr Nowicki,1 Agnieszka Z Wilczewska,2 Halina Car1 1Department of Experimental Pharmacology, Medical University of Bialystok, Bialystok, 15-361, Poland; 2Faculty of Chemistry, University of Bialystok, Bialystok, 15-245, PolandCorrespondence: Katarzyna Niemirowicz-Laskowska; Halina CarDepartment of Experimental Pharmacology, Medical University of Bialystok, Szpitalna 37, Bialystok, 15-361, PolandTel +48602749149; +48604831512Email katarzyna.niemirowicz@umb.edu.pl; halina.car@umb.edu.plAbstract: Nanotherapy is a part of nanomedicine that involves nanoparticles as carriers to deliver drugs to target locations. This novel targeting approach has been found to resolve various problems, especially those associated with cancer treatment. In nanotherapy, the carrier plays a crucial role in handling many of the existing challenges, including drug protection before early-stage degradations of active substances, allowing them to reach targeted cells and overcome cell resistance mechanisms. The present review comprises the following sections: the first part presents the introduction of pharmacoeconomics as a branch of healthcare economics, the second part covers various beneficial aspects of the use of nanocarriers for in vitro, in vivo, and pre- and clinical studies, as well as discussion on drug resistance problem and present solutions to overcome it. In the third part, progress in drug manufacturing and optimization of the process of nanoparticle synthesis were discussed. Finally, pharmacokinetic and toxicological properties of nanoformulations due to up-to-date studies were summarized. In this review, the most recent developments in the field of nanotechnology’s economic impact, particularly beneficial applications in medicine were presented. Primarily focus on cancer treatment, but also discussion on other fields of application, which are strongly associated with cancer epidemiology and treatment, was made. In addition, the current limitations of nanomedicine and its huge potential to improve and develop the health care system were presented.Keywords: nanotechnology, pharmacology, pharmacoeconomic analysis, pharmacoeconomics, nanomaterials synthesis, clinical trials
format	article
author	Milewska S Niemirowicz-Laskowska K Siemiaszko G Nowicki P Wilczewska AZ Car H
author_facet	Milewska S Niemirowicz-Laskowska K Siemiaszko G Nowicki P Wilczewska AZ Car H
author_sort	Milewska S
title	Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment
title_short	Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment
title_full	Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment
title_fullStr	Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment
title_full_unstemmed	Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment
title_sort	current trends and challenges in pharmacoeconomic aspects of nanocarriers as drug delivery systems for cancer treatment
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/61a27f282df04deeb7f555f93121a95c
work_keys_str_mv	AT milewskas currenttrendsandchallengesinpharmacoeconomicaspectsofnanocarriersasdrugdeliverysystemsforcancertreatment AT niemirowiczlaskowskak currenttrendsandchallengesinpharmacoeconomicaspectsofnanocarriersasdrugdeliverysystemsforcancertreatment AT siemiaszkog currenttrendsandchallengesinpharmacoeconomicaspectsofnanocarriersasdrugdeliverysystemsforcancertreatment AT nowickip currenttrendsandchallengesinpharmacoeconomicaspectsofnanocarriersasdrugdeliverysystemsforcancertreatment AT wilczewskaaz currenttrendsandchallengesinpharmacoeconomicaspectsofnanocarriersasdrugdeliverysystemsforcancertreatment AT carh currenttrendsandchallengesinpharmacoeconomicaspectsofnanocarriersasdrugdeliverysystemsforcancertreatment
_version_	1718381028319428608

Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment

Ejemplares similares